ASCO 2019 | Individualized therapy in waldenström’s macroglobulinemia

Name: Individualized therapy in waldenström’s macroglobulinemia
Uploaded: 2019-06-03T00:00:00.000Z
Duration: 1 min 21 s
Description: Jithma Abeykoon, MD, PhD, of the Mayo Clinic, Rochester, MN, explains the importance of individualized therapy in waldenström’s macroglobulinemia. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Jithma Abeykoon • 3 Jun 2019

ASCO 2019

Non-Hodgkin Lymphoma Rare Diseases Waldenström’s Macroglobulinemia

Jithma Abeykoon, MD, PhD, of the Mayo Clinic, Rochester, MN, explains the importance of individualized therapy in waldenström’s macroglobulinemia. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.